|
96
|
292
|
3q53A |
Structure of phosphorylated pak1 kinase domain in complex with atp |
|
93
|
329
|
3q2mA |
Crystal structure of spectinomycin phosphotransferase, aph(9)-ia, protein kinase inhibitor cki-7 complex |
|
113
|
328
|
3pzhA |
Crystal structure of maize ck2 alpha in complex with emodin at 1.92 a resolution |
|
85
|
269
|
3pyyA |
Discovery and characterization of a cell-permeable, small-molecule c-abl kinase activator that binds to the myristoyl binding site |
|
106
|
350
|
3qalE |
Crystal structure of arg280ala mutant of catalytic subunit of camp-dependent protein kinase |
|
107
|
330
|
3qa0A |
Crystal structure of the apo-form of human ck2 alpha at ph 6.5 |
|
99
|
352
|
3q3bA |
6-amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3 inhibitors |
|
82
|
298
|
3pxyA |
Cdk2 in complex with inhibitor jws648 |
|
114
|
332
|
3q9zA |
Crystal structure of human ck2 alpha in complex with quinalizarin at ph 6.5 |
|
113
|
327
|
3pvgA |
Crystal structure of z. mays ck2 alpha subunit in complex with the inhibitor 4,5,6,7-tetrabromo-1-carboxymethylbenzimidazole (k68) |
|
73
|
274
|
3q96A |
B-raf kinase domain in complex with a tetrahydronaphthalene inhibitor |
|
90
|
307
|
3q6uA |
Structure of the apo met receptor kinase in the dually-phosphorylated, activated state |
|
203
|
639
|
3pvuA |
Bovine grk2 in complex with gbetagamma subunits and a selective kinase inhibitor (cmpd101) |
|
90
|
273
|
3pxkA |
Focal adhesion kinase catalytic domain in complex with pyrrolo[2,3-d]thiazole |
|
112
|
357
|
3py3A |
Crystal structure of phosphorylated p38alpha map kinase |
|
104
|
327
|
3pwdA |
Crystal structure of maize ck2 in complex with nbc (z1) |
|
92
|
303
|
3q6wA |
Structure of dually-phosphorylated met receptor kinase in complex with an mk-2461 analog with specificity for the activated receptor |
|
90
|
296
|
3q4zA |
Structure of unphosphorylated pak1 kinase domain |
|
96
|
293
|
3q32A |
Structure of janus kinase 2 with a pyrrolotriazine inhibitor |
|
88
|
302
|
3py1A |
Cdk2 ternary complex with su9516 and ans |
|
84
|
298
|
3pxrA |
Apo cdk2 crystallized from jeffamine |
|
166
|
490
|
3q5iA |
Crystal structure of pbanka_031420 |
|
72
|
289
|
3pwyA |
Crystal structure of an extender (spd28345)-modified human pdk1 complex 2 |
|
110
|
363
|
3q60A |
Crystal structure of virulent allele rop5b pseudokinase domain bound to atp |
|
96
|
298
|
3q4uA |
Crystal structure of the acvr1 kinase domain in complex with ldn-193189 |
|
78
|
302
|
3pxqA |
Cdk2 in complex with 3 molecules of 8-anilino-1-naphthalene sulfonate |
|
73
|
284
|
3qc4A |
Pdk1 in complex with dfg-out inhibitor xxx |
|
82
|
302
|
3pxzA |
Cdk2 ternary complex with jws648 and ans |
|
81
|
345
|
3pvbA |
Crystal structure of (73-244)ria:c holoenzyme of camp-dependent protein kinase |
|
96
|
293
|
3q52A |
Structure of phosphorylated pak1 kinase domain |
|
68
|
276
|
3psdA |
Non-oxime pyrazole based inhibitors of b-raf kinase |
|
91
|
317
|
3pozA |
Egfr kinase domain complexed with tak-285 |
|
88
|
268
|
3piyA |
Crystal structure of btk kinase domain complexed with r406 |
|
94
|
268
|
3pixA |
Crystal structure of btk kinase domain complexed with 2-isopropyl-7-(4-methyl-piperazin-1-yl)-4-(5-methyl-2h-pyrazol-3-ylamino)-2h-phthalazin-1-one |
|
108
|
350
|
3pg3A |
Human p38 map kinase in complex with rl182 |
|
107
|
348
|
3p79A |
P38 inhibitor-bound |
|
75
|
276
|
3ppkA |
Human b-raf kinase in complex with a non-oxime furopyridine inhibitor |
|
81
|
269
|
3pizA |
Crystal structure of btk kinase domain complexed with (5-amino-1-o-tolyl-1h-pyrazol-4-yl)-[3-(1-methanesulfonyl-piperidin-4-yl)-phenyl]-methanone |
|
81
|
269
|
3pj1A |
Crystal structure of btk kinase domain complexed with 3-(2,6-dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one |
|
78
|
266
|
3pa4A |
X-ray crystal structure of compound 2a bound to human chk1 kinase domain |
|
88
|
290
|
3pjcA |
Crystal structure of jak3 complexed with a potent atp site inhibitor showing high selectivity within the janus kinase family |
|
110
|
569
|
3pfqA |
Crystal structure and allosteric activation of protein kinase c beta ii |
|
108
|
327
|
3pe1A |
Crystal structure of human protein kinase ck2 alpha subunit in complex with the inhibitor cx-4945 |
|
75
|
276
|
3ppjA |
Human b-raf kinase in complex with a furopyridine inhibitor |
|
90
|
298
|
3plsA |
Ron in complex with ligand amp-pnp |
|
82
|
269
|
3pj2A |
Crystal structure of btk kinase domain complexed with 2-[4-(2-diethylamino-ethoxy)-phenylamino]-6-(4-fluoro-phenoxy)-8-methyl-8h-pyrido[2,3-d]pyrimidin-7-one |
|
72
|
263
|
3p9jA |
Aurora a kinase domain with phthalazinone pyrazole inhibitor |
|
98
|
356
|
3ptgA |
Design and synthesis of a novel, orally efficacious tri-substituted thiophene based jnk inhibitor |
|
79
|
299
|
3pj8A |
Structure of cdk2 in complex with a pyrazolo[4,3-d]pyrimidine bioisostere of roscovitine. |
|
81
|
269
|
3pj3A |
Crystal structure of btk kinase domain complexed with 2-methyl-5-[(e)-(3-phenyl-acryloyl)amino]-n-(2-phenyl-3h-imidazo[4,5-b]pyridin-6-yl)-benzamide |
